ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO) Files An 8-K Other EventsItem 8.01 Other Events
On November 8, 2017 the Company released the President’s Report To Shareholders dated November 8, 2017, a copy of which is filed herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
Exhibit 99.1 –President’s Report to Shareholders dated November 8, 2017.
Zivo Bioscience, Inc. ExhibitEX-99.1 2 f8k110717_ex99z1.htm EXHIBIT 99.1 PRESIDENT’S REPORT TO SHAREHOLDERS DATED NOVEMBER 8,…To view the full exhibit click
About ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO)
Zivo Bioscience, Inc., formerly Health Enhancement Products, Inc., is a biotechnology company. The Company is engaged in the study, development and commercialization of naturally derived compounds and bioactive molecules created by algal and bacterial hosts. The Company focuses on research and identification of its bioactive ingredients. It focuses to sell natural bioactive ingredients derived from its algae cultures to animal, human and dietary supplement and medical food manufacturers. It is also engaged in development of biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation. It focuses on developing, manufacturing, marketing and selling tests that allow users to optimize personal health and identify future health risks. The Company manufactures algal products and derivatives, and has various product platforms.